↓ Skip to main content

Dove Medical Press

Encorafenib/binimetinib for the treatment of BRAF-mutant advanced, unresectable, or metastatic melanoma: design, development, and potential place in therapy

Overview of attention for article published in OncoTargets and therapy, December 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

twitter
3 X users
patent
2 patents

Citations

dimensions_citation
41 Dimensions

Readers on

mendeley
61 Mendeley